脂多糖学
肝细胞癌
甘油磷脂
临床化学
机制(生物学)
重编程
癌症研究
生物
医学
生物化学
基因
膜
认识论
哲学
磷脂
作者
Yanran Bi,Xihui Ying,Wanbin Chen,Jiahao Wu,Chunli Kong,Weiming Hu,Shiji Fang,Junchao Yu,Mengqian Zhai,Chengli Jiang,Minjiang Chen,Lin Shen,Jiansong Ji,Tu Jianfei
标识
DOI:10.1186/s12944-024-02298-4
摘要
Metabolic reprogramming, a key mechanism regulating the growth and recurrence of hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA), still lacks effective clinical strategies for its integration into the precise screening of primary liver cancer. This study utilized ultra-high-performance liquid chromatography with quadrupole time-of-flight mass spectrometry to conduct a comprehensive, non-targeted metabolomics analysis, revealing significant upregulation of lipid metabolites such as phosphatidylcholine and lysophosphatidylcholine in patients with HCC and CCA, particularly within the glycerophospholipid metabolic pathway. Hematoxylin and eosin and immunohistochemical staining demonstrated marked upregulation of phospholipase A 2 in tumor tissues, further emphasizing the potential of lipid metabolism as a therapeutic target and its important part in the course of cancer. This work provides a new viewpoint for addressing the clinical challenges associated with HCC and CCA, laying the groundwork for the broad application of early diagnosis and personalized treatment strategies, and ultimately aiming to provide tailored and precise therapeutic options for patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI